In the June 26, 2024, Customs Bulletin and Decisions, U.S. Customs and Border Protection is reclassifying sildenafil citrate in bulk form as a sulfonamide under HTSUS 2935.90.60 (duty-free under the Pharmaceutical Appendix) rather than as a heterocyclic compound with nitrogen heteroatoms only under HTSUS 2933.59.5300 (duty-free under the Pharmaceutical Appendix).

Ruling HQ H261406 will revoke rulings NY H83763 and NY B87488 to reflect this change, effective with respect to goods entered or withdrawn from warehouse for consumption on or after Aug. 26.

The product at issue is a drug that produces the dilatation of blood vessels and is used to treat erectile dysfunction and high blood pressure in the lungs.

For more information on how to seek or utilize classification and other rulings, please contact attorney Deb Stern at (305) 894-1007 or via email.

Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 


Cookie Consent

We have updated our Privacy Policy relating to our use of cookies on our website and the sharing of information. By continuing to use our website or subscribe to our publications, you agree to the Privacy Policy and Terms & Conditions.